An Fc-binding glycoprotein, designated gE, was detected previously in cells infected with herpes simplex virus type 1 (HSV-1) and in virion preparations isolated from infected cells. For the studies reported here, we purified gE from HSV-1 strain HFEM(syn) by affinity chromatography and preparative electrophoresis and then immunized a rabbit to produce an antiserum to glycoprotein gE. We found that this antiserum selectively precipitated gE and its precursors from detergent-solubilized extracts of HSV-1 strain HFEM(syn)-infected HEp-2 cells, from extracts of other cell lines infected with the same virus, and from extracts of HEp-2 cells infected with several other HSV-1 strains. The antiserum did not precipitate any proteins from uninfected cells. The several forms of gE detected by immunoprecipitation accumulated in variable quantities in different cells infected with the different virus strains and also varied slightly with respect to electrophoretic mobility, suggesting some differences in the gE's from different HSV-1 strains and some effects of the host cell on the nature and extent of posttranslational processing. One of the electrophoretic forms of gE previously detected in purified preparations of virions could be precipitated by anti-gE from extracts of purified HSV-1 strain HFEM(syn) virions. Moreover, anti-gE neutralized HSV-1 infectivity, but only in the presence of complement. Finally, F(ab')2 fragments of the anti-gE immunoglobulin partially inhibited the binding of 125I-labeled immunoglobulin G to the Fc receptors on HSV-1-infected cells.
Infection of cultured cells with herpes simplex virus (HSV) results in the expression of receptors for the Fc region of immunoglobulin G (IgG) (27, 29, 30) . These receptors, whose physiological significance is not yet understood, have been detected after infection of a variety of different cell types, including cells of fibroblastic, epithelial, and hematopoietic origin (7, 8, 12, 18, 19, 29) . In addition, other human herpesviruses (specifically, cytomegalovirus [15, 23, 28] and varicella-zoster virus [21] ) have also been reported to induce the expression of Fc-binding receptors.
Recently, we reported the use of affinity chromatography to identify three electrophoretically distinguishable Fc-binding polypeptides, some or all of which were glycosylated, in extracts of HSV type 1 (HSV-1)-infected cells (2) . The results of pulse-chase experiments and comparisons of proteolytic digestion products indicated that the three polypeptides were derived from the same gene product (designated gE) and that they probably differed in the extent of glycosylation or other post-translational proc- essing. The Fc-binding activity of gE, coupled with the appearance of gE on the cell surface concomitant with the expression of Fc-binding receptors on intact cells, suggested that gE might in fact be the receptor.
To characterize gE further and to investigate the relationship of gE to Fc-binding activity on cell surfaces and virions, we purified this glycoprotein and prepared an antiserum against it. In this paper we report that the antiserum selectively precipitated gE and its precursors from a variety of cell types infected with several different HSV-1 strains, that it neutralized HSV-1 infectivity in the presence of complement, and that F(ab')2 fragments of immunoglobulins from the anti-gE serum interfered with the Fc-binding in medium 199 supplemented with 1% heat-inactivated calf serum (medium 199V) . For viral titrations, Vero cells were used, and the overlay medium (medium 199V) contained 0.1% pooled human gamma globulin (24) . The viruses used in this study were HSV-1 strains F (11), mP (14) , MP (14), 14- Immunoprecipitation. Proteins were solubilized from infected or uninfected cells or from purified virions for immunoprecipitation experiments. The cells from 25-cm2 monolayer cultures were washed with PBS lacking MgCl2 and CaC12, lysed in 1 ml of extraction buffer (Ca2+-and Mg2+-free PBS containing 0.1% SDS, 0.5% sodium deoxycholate, and 1% Nonidet P-40), and then frozen at -20°C until they were used. Similarly, purified virions were collected by centrifugation and lysed in extraction buffer (1 ml of purified virions [approximately 3 x 109 PFU] from 109 cells). Before immunoprecipitation the lysates were thawed, and insoluble material was removed by centrifugation at 25,000 rpm in an SW27.1 rotor for 2 h; 0.1 to 1 ml of extract was mixed with 10 ,ul of serum and placed on ice for 1 h. To separate the immune complexes from the unreacted material, 100 ,ul of Formalin-fixed S. aureus (10o [vol/voll in extraction buffer containing 0.1% ovalbumin) was added, and the mixtures were left for an additional 1 h on ice. The S.
aureus cells with bound immune complexes were collected by centrifugation in a microfuge. To remove non-specifically adsorbed proteins, the pellets were washed by two suspensions in extraction buffer and recentrifugation. Then a third wash was performed with 50 mM Tris-hydrochloride (pH 7.5) containingpolyacrylamide electrophoresis (13) . The gels were fixed and stained, and the radioactive bands were located by fluorography (3).
Neutralization. We tested antibody-mediated neutralization of viral infectivity in the presence and absence of complement by using a plaque reduction assay. We prepared mixtures which contained approximately 500 PFU of HSV-1 strain HFEM(syn) per ml, 20 Pd of serum (either immune or preimmune and either untreated or heated to 56°C for 30 min) per ml, and different concentrations of guinea pig complement. These mixtures were incubated at 37°C for 1 h, and 1-ml samples were added to Vero cell monolayers for 2 h at 37°C with shaking to assay for residual infectious virus, as described above for viral titration.
F(ab')2 Inhibition of 125I-labeled IgG biding. F(ab')2 fragments were prepared from Na2SO4-precipitated immunoglobulins obtained from anti-gE serum and normal rabbit serum. The precipitated proteins were collected by centrifugation at 7,500 x g for 20 min at room temperature. The precipitate was reconstituted in water and dialyzed against 0.0175 M phosphate buffer (pH 6.9). The IgG fraction was isolated by chromatography on DEA-Bio-Gel, as described previously (22) . The F(ab')2 fragments were prepared by a modification (2, 22) of the pepsin digestion method of Nisonoff (20) . The IgG used in the binding assay was with HSV-1 strain HFEM(syn) at a multiplicity of 10 PFU/cell. The inoculum was removed after 2 h, and the cells were incubated in medium 199 without serum. At 18 h after infection, the medium was removed, and the cells were rinsed with PBS and then incubated at 370C with different concentrations of F(ab')2 fragments in 1 ml of borate-buffered saline (experiment 1) or PBS (experiment 2). After 1 h, 0.5 ml of buffer (boratebuffered saline or PBS) containing 25 Fig. 1A shows, only one polypeptide was precipitated from extracts of cells harvested immediately after the pulse, and its apparent molecular weight was about 65,000, compared with a molecular weight of 80,000 for the stable immunoprecipitable forms. Increasing the time of incubation in nonradioactive medium resulted in the disappearance of the 65,000-molecular-weight species and apparent sequential modifications of the immunoreactive pulselabeled polypeptide to yield multiple diffuse bands of protein with apparent molecular weights of 80,000 to 85,000. The 6-h chase yielded a stable immunoprecipitable polypeptide with an apparent molecular weight of 80,000, which corresponded to the species found in continuously labeled cells and in virions (see below). The stable and transient forms of the polypeptide detected by immunoprecipitation had the same electrophoretic mobilities as similarly stable and transient polypeptides previously identified by their Fc-binding activity; the Fc-binding polypeptides were also shown previously to share amino acid sequences in common and were collectively designated gE (2) .
Immunoprecipitation of gE from various cell types. To determine whether HSV-1 induced the synthesis of gE in various species and types of cells, we infected BHK-21, HEL, Vero, and HEp-2 cells with HSV-1 strain HFEM(syn), and the proteins solubilized from each preparation were mixed with anti-gE serum for immunoprecipitation. Figure 2 shows Fig. 3 shows, polypeptides that were antigenically related to the gE of HSV-1 strain HFEM(syn) were produced by all strains and exhibited approximately the same electrophoretic mobility. Multiple forms of gE were precipitated from all of the extracts except the extract from HSV-1 strain MP-infected cells, in contrast to the results shown in Fig. 1 The volume of unfractionated virion extract analyzed in the gel shown in Fig. 4 was only a small proportion of the volume used to obtain the immunoprecipitate (Fig. 4, lane a) . Prolonged exposure of the gel (Fig. 4, lanes d and e) did not reveal any polypeptides precipitated by the preimmune serum but did reveal minor additional polypeptides in the anti-gE precipitate. The presence of these polypeptides could reflect the presence of antibodies other than anti-gE in the serum or some proteolytic digestion products of gE or, more likely, the nonspecific entrapment of material in immune complexes. The anti-gE serum was tested for neutralizing activity. As Fig. 5 shows, the unheated antiserum was capable of neutralizing infectious HSV-1 strain HFEM(syn). However, this activity was entirely complement dependent in that it was heat labile (56°C, 30 min) and could be reconstituted by the addition of guinea pig complement. The complement dependence of this viral neutralization by the serum from the immunized rabbit persisted for several months after multiple immunizations and thus apparently was not solely due to the early or transient complement- requiring antibodies elicited shortly after the primary immunization. In addition, when the isolated IgG fraction of the serum was supplemented with complement, it contained a significant amount of the neutralizing activity, if not all of it (data not shown). Finally, the neutralizing activity was not due to anticellular antibodies because adsorption of anti-gE with uninfected cells failed to reduce its activity.
Inhibition of 1251-labeled IgG binding by F(ab')2 fragments from anti-gE. Preincubation of F(ab')2 fragments from anti-HSV serum (but not normal serum) with HSV-infected cells reportedly inhibits subsequent 125I-labeled IgG binding to these cells (1, 18 2) was used. In addition, different batches of antiserum (second and third immune bleedings, respectively) were used to obtain the F(ab')2 fragments. gene product. Whether any significance should be attached to the apparent differences in the amounts and electrophoretic mobilities of the labeled gE's precipitated from the different cell types is questionable for the reasons indicated above.
Immunoprecipitation of gE from extracts of purified virions and the neutralization of viral infectivity by anti-gE serum indicate that gE is present in virions and has some antigenic determinants exposed on the surface, even though we cannot be absolutely certain that anti-gE antibodies are entirely responsible for the neutralization. The finding that neutralization depends on the presence of complement is interesting and provides one explanation for the common observation that complement enhances the neutralization of polyspecific sera. It remains to be determined whether it is possible to raise complement-independent neutralizing antibodies specific for gE. 
